Jeon and co-workers demonstrated the AXL suppressor Q702 decreased the expression of TAM signature genes and upregulated MHC-I signature genes in tumor samples, and also reported upregulated CD8 T cell and NK cell signature genes in a time-dependent manner (83). This evidence concerns the gene CD8A and neoplasm.